Thibault M.
- Country
- France
- Department
- oncology
Research Overview
- Phase 2 Randomized Open‑Label Study of Denikitug Monotherapy and Denikitug‑Based Combination Therapy in Adults with Advanced Microsatellite Stable Colorectal Cancer
- Evaluation of Petosemtamab Monotherapy and Combination Therapy in Advanced Metastatic Colorectal Cancer and Malignant Solid Tumors
- Phase 1/2 Study of EO4010 with Nivolumab and/or Bevacizumab in Previously Treated Metastatic Colorectal Carcinoma
Data & Insights
Has run more than one trial at 143 of 313 partner sites.
Specializations
Colorectal Cancer Research
Specializes in investigating advanced treatments for metastatic colorectal cancer, with particular focus on genetic variations including KRAS/NRAS and BRAF wild-type tumors.
- MSI-H/dMMR targeted therapies
- Combination immunotherapy approaches
- Novel therapeutic combinations with chemotherapy
Investigates innovative treatment strategies including immune checkpoint inhibitors and targeted molecular therapies for various colorectal cancer subtypes.
Head and Neck Cancer Studies
Conducts research in head and neck squamous cell carcinoma (HNSCC) treatment, focusing on both first-line and subsequent therapy options.
- PD-L1 positive tumor treatments
- Novel monoclonal antibody therapies
- Combination treatment strategies
Explores innovative therapeutic approaches for recurrent and metastatic head and neck cancers using targeted and immunological treatments.
Immunotherapy Innovation
Focuses on developing immunotherapy-based treatment approaches across multiple cancer types, particularly in combination with targeted therapies.
- Checkpoint inhibitor combinations
- Novel cancer vaccine therapies
- Immune response modulation
Investigates innovative immunological approaches in treating resistant and advanced cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.